Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
ULIS-1 is an open-label pilot study concerning utility of molar sodium lactate in fluid balance in septic shock patients
Full description
ULIS-1 consists in three arms of treatment during the first 24hrs of septic shock treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
90 participants in 3 patient groups
Loading...
Central trial contact
Raphaël Favory, MD,PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal